Brief: Clover Presents Updated Durability And Booster Data For COVID Vaccine Candidate At World Vaccine Congress Washington 2022
19/04/2022 12:33
April 19 (Reuters) - Clover Biopharmaceuticals Ltd
2197.HK :
* CLOVER PRESENTS UPDATED DURABILITY AND BOOSTER DATA FOR
COVID-19
VACCINE CANDIDATE AT WORLD VACCINE CONGRESS WASHINGTON 2022
* CLOVER BIOPHARMACEUTICALS LTD- NO SAFETY CONCERNS WERE
OBSERVED
IN INDIVIDUALS DOSED WITH SCB-2019 (CPG 1018/ALUM) WITHIN
FOLLOW-UP PERIOD
Source text for Eikon: ID:nGNX7VZWDm
Further company coverage: 2197.HK
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune